Aprocitentan

Another Name
ACT-132577 LuciApro 阿普昔腾片
Indications
Cardiovascular Disease,Resistant Hypertension.
Reg No
08L 1181/24
Inspection No
2025-24
dosage form:Tablets
Specs:12.5mg * 30 Tablets
Indate:2 Years
Date:2024-9-3 Views:1217

COMPOSITION:

Each film-coated tablet contains Aprocitentan……………………………12.5mg.

INDICATION:

LuciApro is an endothelin receptor antagonist indicated for the treatment of hypertension in combination with other antihypertensive drugs, to lower blood pressure in adult patients who are not adequately controlled on other drugs. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.

DOSAGE AND USE:

• The recommended dosage of LuciApro is 12.5 mg orally once daily, with or without food.

STORAGE:

In a dry place and store at 20°C to 25°C.

MANUFACTURED AND MARKETED BY:

LUCIUS PHARMACEUTICALS(LAO) CO., LTD

No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos

WARNING:

Keep medicine out of reach of Children. Do not administer LuciApro during Pregnancy and Lactation.

Original article, if reprinted, please indicate the link to this article: https://lucius-pharmaceuticals.com/drug/aprocitentan/

Related News